Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 56, Issue 1, Pages 552-554Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00473-11
Keywords
-
Categories
Funding
- NIH [AI60507, AI33774-11, HL59842-07, AI33142-11, AI52733-02, GM 07142-01]
- European Commission
Ask authors/readers for more resources
We investigated the utility of radioimmunotherapy (RIT) in early and established cryptococcal infection in immunocompetent mice. RIT with Bi-213-18B7 antibody completely eliminated fungus from mouse lungs and brains for early infection, while Re-188-18B7 significantly reduced CFU in the lungs or both lungs and brains during early and established infection, respectively. The results point to the independence of RIT of the immune status of the host, which is encouraging for translation of this strategy into the clinic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available